Ibrance (palbociclib)

pCPA File Number: 20964

Negotiation Status:

Concluded with an LOI

Indication(s):

Advanced Breast Cancer

Sponsor/Manufacturer:

Pfizer Canada ULC

CDA-AMC Project Number:

PC0093-000

pCPA Engagement Letter Issued:

2017-05-15

Negotiation Process Concluded:

2017-12-21